Select Net Tangible Assets vs Deferred Long Term Liab Analysis
SEM Stock | USD 32.73 0.62 1.93% |
Select Medical financial indicator trend analysis is much more than just breaking down Select Medical Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Select Medical Holdings is a good investment. Please check the relationship between Select Medical Net Tangible Assets and its Deferred Long Term Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Net Tangible Assets vs Deferred Long Term Liab
Net Tangible Assets vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Select Medical Holdings Net Tangible Assets account and Deferred Long Term Liab. At this time, the significance of the direction appears to have no relationship.
The correlation between Select Medical's Net Tangible Assets and Deferred Long Term Liab is 0.0. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Select Medical Holdings, assuming nothing else is changed. The correlation between historical values of Select Medical's Net Tangible Assets and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Select Medical Holdings are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Net Tangible Assets i.e., Select Medical's Net Tangible Assets and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | 0.0 |
Relationship Direction | Flat |
Relationship Strength | Insignificant |
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Select Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Select Medical Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. At this time, Select Medical's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 8th of May 2024, Enterprise Value Over EBITDA is likely to grow to 9.89, while Tax Provision is likely to drop about 75.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 136.0M | 169.1M | 198.6M | 152.3M | Depreciation And Amortization | 252.4M | 232.2M | 208.7M | 141.4M |
Select Medical fundamental ratios Correlations
Click cells to compare fundamentals
Select Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Select Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.3B | 7.7B | 7.4B | 7.7B | 7.7B | 4.9B | |
Short Long Term Debt Total | 4.5B | 4.5B | 4.7B | 5.1B | 5.0B | 2.9B | |
Other Current Liab | 535.4M | 623.8M | 708.4M | 687.3M | 735.7M | 772.5M | |
Total Current Liabilities | 914.3M | 1.4B | 1.3B | 1.2B | 1.2B | 713.0M | |
Total Stockholder Equity | 929.0M | 1.1B | 1.3B | 1.3B | 1.3B | 788.0M | |
Property Plant And Equipment Net | 2.0B | 2.0B | 2.0B | 2.2B | 2.2B | 2.3B | |
Net Debt | 4.2B | 3.9B | 4.6B | 5.0B | 4.9B | 2.8B | |
Retained Earnings | 279.8M | 553.2M | 593.3M | 581.0M | 751.9M | 789.4M | |
Accounts Payable | 145.7M | 177.1M | 233.8M | 186.7M | 174.3M | 131.2M | |
Cash | 335.9M | 577.1M | 74.3M | 97.9M | 84.0M | 110.8M | |
Non Current Assets Total | 6.1B | 6.1B | 6.2B | 6.4B | 6.4B | 4.0B | |
Non Currrent Assets Other | 323.9M | 319.2M | 356.7M | 341.7M | 39.6M | 37.7M | |
Cash And Short Term Investments | 335.9M | 577.1M | 74.3M | 97.9M | 143.0M | 115.1M | |
Net Receivables | 762.7M | 896.8M | 889.3M | 941.3M | 940.3M | 597.3M | |
Good Will | 3.4B | 3.4B | 3.4B | 3.5B | 3.5B | 2.5B | |
Common Stock Shares Outstanding | 130.3M | 129.8M | 130.2M | 124.6M | 123.1M | 134.7M | |
Liabilities And Stockholders Equity | 7.3B | 7.7B | 7.4B | 7.9B | 7.7B | 4.9B | |
Non Current Liabilities Total | 5.5B | 5.0B | 4.8B | 5.2B | 4.9B | 3.3B | |
Other Current Assets | 114.4M | 114.5M | 175.8M | 232.1M | 151.6M | 233.2M | |
Other Stockholder Equity | 649.1M | 509.1M | 720.2M | 647.8M | 493.4M | 584.2M | |
Total Liab | 6.4B | 6.4B | 6.0B | 6.3B | 6.1B | 4.1B | |
Property Plant And Equipment Gross | 2.0B | 2.0B | 2.0B | 1.0B | 3.6B | 3.8B | |
Total Current Assets | 1.2B | 1.6B | 1.1B | 1.3B | 1.3B | 829.8M | |
Accumulated Other Comprehensive Income | 0.0 | (2.0M) | 12.3M | 88.6M | 42.9M | 45.1M | |
Short Term Debt | 233.1M | 233.0M | 246.9M | 281.1M | 346.0M | 363.3M | |
Intangible Assets | 409.1M | 387.5M | 374.9M | 351.7M | 329.9M | 233.3M | |
Other Liab | 249.6M | 301.1M | 249.2M | 275.9M | 317.3M | 200.2M | |
Other Assets | 93.2M | 1.4B | 356.7M | 94.3M | 108.5M | 202.7M | |
Long Term Debt | 3.4B | 3.4B | 3.6B | 3.8B | 3.6B | 2.6B | |
Property Plant Equipment | 998.4M | 943.4M | 961.5M | 2.2B | 2.5B | 2.6B | |
Net Tangible Assets | (2.1B) | (2.3B) | (2.7B) | 804.3M | 723.9M | 760.1M | |
Noncontrolling Interest In Consolidated Entity | 158.1M | 192.5M | 215.9M | 234.6M | 269.8M | 283.3M | |
Retained Earnings Total Equity | 279.8M | 553.2M | 593.3M | 581.0M | 668.2M | 401.2M | |
Long Term Debt Total | 3.4B | 3.4B | 3.6B | 3.8B | 4.4B | 2.9B | |
Capital Surpluse | 491.0M | 509.1M | 504.3M | 452.2M | 520.0M | 521.3M |
Currently Active Assets on Macroaxis
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Select Medical Holdings information on this page should be used as a complementary analysis to other Select Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Select Stock analysis
When running Select Medical's price analysis, check to measure Select Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Select Medical is operating at the current time. Most of Select Medical's value examination focuses on studying past and present price action to predict the probability of Select Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Select Medical's price. Additionally, you may evaluate how the addition of Select Medical to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Select Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.356 | Dividend Share 0.5 | Earnings Share 2.1 | Revenue Per Share 54.993 | Quarterly Revenue Growth 0.074 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.